Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

607 public trials 71 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

NCT01698905

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • USC Kenneth Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Indiana Blood and Marrow Institute Beech Grove, Indiana, United States
  • St Agnes Hospital Baltimore, Maryland, United States
  • University of Texas Medical Branch Galveston, Texas, United States
View all 62 locations
View Trial Details
Completed

OPTIM DASATINIB (Optimized Tyrosine Kinase Inhibitors Monotherapy)

NCT01916785

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, BCR/ABL Positive, +11 more
Locations
  • Southern Alberta Cancer Research Institute Calgary, Canada
  • Hôpital Charles LeMoyne Greenfield Park, Canada
  • Queen elisabeth II Health Sciences Center Halifax, Canada
  • CH Pierre LeGardeur Lachenaie, Canada
View all 34 locations
View Trial Details
Completed

Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation

NCT06427811

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +22 more
Locations
  • Novartis Investigative Site Ahmedabad, Gujarat, India
  • Novartis Investigative Site Ahmedabad, Gujarat, India
  • Novartis Investigative Site Bengaluru, Karnataka, India
  • Novartis Investigative Site Trivandrum, Kerala, India
View Trial Details
Completed

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

NCT02220985

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
Locations
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2)

NCT01774630

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • CHU Angers Angers, France
  • Institut Bergonié Bordeaux, France
  • Centre Hospitalier de Versailles - Hôpital André Mignot - Service de Médecine B Le Chesnay, France
  • CHU de Nice, Service Hématologie Clinique Nice, France
View Trial Details

Related conditions